⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

263.81USD

-3.8000 (-1.42%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on JNJ.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
In $M except per-shareQ3 FY26Q2 FY26Q1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*
Revenue25,39925,31024,06224,56423,99323,74321,89322,520
Cost of Revenue8,0978,0518,1067,9687,3037,6287,3577,128
Gross Profit17,30217,25915,95616,59616,69016,11514,53615,392
Operating Income————————
Net Income2105,5345,2355,1165,1525,53710,9993,431
EPS (Diluted)$0.09$2.27$2.14$2.09$2.12$2.29$4.54$1.41

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)